Lyell Immunopharma
Venture Capital
Lyell is a clinical-stage company advancing next-generation CAR T-cell product candidates for patients with cancer.
Biotech
- Website
- lyell.com
- Last Investment
- Sep 2020
Investment History
Sign up to view investment history
Create a free account to see deal history, investment amounts, and round details.
Create Free Account